Robert is accredited by the American Statistical Association with 25 years of industry experience as a research biostatistician.  He brings his expertise in statistical analysis, algorithm development, and modeling to support the development and approval of medical devices, diagnostic assays, or drug discovery.  He specializes in clinical trial design and analysis (Phases 1-3) and translational medicine and actively engages in FDA regulatory meetings. 

 

Robert has contributed to drug development, biomarker identification, and pre- and post-clinical analysis, adhering to industry standards like CDISC. He thrives in collaborative research environments and is proficient in statistical packages such as R, SAS, SPSS, and Plink.  

 

With a solid academic background, Robert is committed to advancing his field through innovative statistical methods.  

 

Outside of work, Robert enjoys cooking, live music, and enjoying the company of family and friends.